Direct access to our audited laboratory verification programs, high-throughput active ingredient identification, preclinical toxicology models, and commercial extraction modules.
A comprehensive examination of how the global healthcare, pharmaceutical, and functional nutraceutical markets are shifting from generic herbal powder processing toward high-precision molecular identification, reproducible extraction chemistry, and empirical clinical validation.
Global regulatory agencies including the US FDA (21 CFR Part 111/312), the European Medicines Agency (EMA/HMPC), and the NMPA demand uncompromising proof of phytochemical identity, assay reproducibility, stability profiles, and total heavy-metal/solvent clearance. Pure bulk blending is no longer competitive; only quantifiable active fractions survive regulatory audits.
Modern consumers and institutional buyers require botanical integrity tracking from geopositioned soil origin through harvest lifecycle to final solvent recovery. Uncontrolled batch variances degrade therapeutic efficacy and destroy brand equity in premium OTC and functional beverage formulations.
Pharmaceutical conglomerates are increasingly screening polyherbal traditional formulations (TCM) to discover novel biological targets for metabolic health, immuno-oncology, and neuroprotection. Bridging empirical historical medicine with contemporary molecular pharmacology requires specialized CRO partner depth.
Operating at the convergence of direct agro-botanical origin diversity, advanced chemical engineering infrastructure, and high-density technical talent.
Eliminate costly tech-transfer friction. Our fully owned pilot facilities and scaled commercial manufacturing clusters allow experimental bench protocols to advance immediately into 10,000-liter continuous counter-current extractors without third-party margin degradation.
Direct supply partnerships across regional agricultural planting bases guarantee authentic Daodi herb origins. Multi-season botanical evaluations ensure optimal harvest timing when target active fractions reach peak molecular density.
A multi-disciplinary research matrix featuring phytochemists, pharmacologists, toxicologists, and process engineers capable of executing parallel assay screening, impurity tracing, and rapid analytical method validation within compressed client timeframes.
Entrusted research contracts operate under ironclad non-disclosure protocols. Molecular formulations, process parameters, purification resin chemistry, and downstream batch profiles remain the exclusive commercial property of the client.
Quantifiable R&D outcomes built over 14+ years of entrusted execution for leading clinical and commercial institutions.
Years of Continuous Natural Medicine & Phytochemical R&D
Internal Research Scientists, Toxicologists & Engineers
Global Pharma Manufacturers & Hospital Systems Serviced
Classic Traditional Herbal Formulations Fully Modernized
Innovative New Natural Medicine Entities Developed
Hospital Clinical Preparation Registrations Successfully Obtained
Single-Herb Extraction Standards & Fingerprints Established
Contractual IP Confidentiality & Entrusted Stewardship
Eliminate R&D bottlenecks through a tightly governed milestone structure where each gate requires analytical, safety, and operational validation before scaling capital expenditure.
High-resolution screening of alkaloids, saponins, flavonoids, and polysaccharides across multiple geographic regions, soil types, and seasonal harvest periods.
Establishment of validated qualitative and quantitative analytical protocols using HPLC-DAD, LC-MS/MS, GC-FID, HPTLC, and chromatographic fingerprinting.
Engineering pilot extraction parameters, macroporous resin adsorption, nanofiltration, spray-drying, and crystallization parameters to maximize industrial yield.
Assessing safety and biological activity through cellular assays, LD50 acute toxicity, chronic sub-acute organ evaluations, and genotoxicity Ames tests.
Execution of small-cohort dietary supplement efficacy trials or full GCP-compliant Phase I through IV clinical trials required for pharmaceutical drug registrations.
Transitioning validated formulations into scaled commercial production: active bulk extracts, functional powders, softgels, capsules, tablets, or liquid vials.
Customizing chemical architecture and physical stability to meet strict regional regulatory requirements across dietary, drug, and dermaceutical channels.
Empirical evidence substantiation for functional nutrition brands. We engineer high-solubility, taste-masked botanical extracts calibrated for RTD drinks, effervescent powders, softgel suspensions, and clean-label chewables.
High-purity botanical active pharmaceutical ingredients (APIs). Complete chemical characterization, impurity profiling, degradation mechanics, and stability under ICH Q1A guidelines to support new drug applications.
Bioactive phytochemicals with verified transdermal permeation, anti-inflammatory, antioxidant, or melanogenesis inhibition profiles. Fully tested via 3D skin model assays and cosmetic safety compliance.
Our analytical protocols and manufacturing standards have been vetted and commissioned by tier-one pharmaceutical organizations, state hospitals, and university research facilities.
Key technical answers regarding contract research deliverables, regulatory compliance, quality verification, and intellectual property insulation.
We provide full-lifecycle contract research and development for plant-derived ingredients and polyherbal formulations. Our scopes span initial raw material screening, regional/seasonal potency evaluation, analytical method establishment (HPLC, HPTLC, GC), process engineering, GLP-compliant preclinical safety (LD50, acute, chronic, genotoxicity), in vitro cellular assays, animal models, GCP clinical trials (Phase I to IV), and scaled CDMO finished batch supply.
Yes. MedGence integrates in-house analytical laboratories with dedicated pilot processing facilities and closely managed industrial extraction plants. Study outcomes, resin adsorption ratios, and spray-drying temperature profiles transition directly without the information loss, delay, or yield reduction typical when research and CDMO production are separated.
We utilize comprehensive chromatographic fingerprints combining High-Performance Thin-Layer Chromatography (HPTLC) for qualitative identification, High-Performance Liquid Chromatography (HPLC-DAD/MS) for active fraction quantification, Gas Chromatography (GC) for volatile components and residual solvents, and Atomic Absorption Spectroscopy (AAS/ICP-MS) for heavy metal safety profiles.
All contract research and customized extraction programs execute under rigorous bilateral Non-Disclosure Agreements (NDA). All intellectual property generated, including chemical fractionation parameters, excipient selections, stability logs, and master batch records (MBRs), belongs exclusively to the commissioning client.
For active pharmaceutical ingredients and bulk nutraceuticals: standardized dried extract powders, concentrated liquids, vacuum pastes, and volatile essential oils. For commercial packaged finished goods: oral liquid bottles, two-piece hard gelatin or vegetarian capsules, oil/suspension softgels, immediate or sustained-release tablets, effervescent powders, and micro-granules.
Yes. Beyond small-cohort pilot efficacy trials for dietary supplements, we design, manage, and audit formal GCP Phase I (safety/PK), Phase II (dose-ranging), Phase III (large-scale pivotal multi-center verification), and Phase IV (post-market surveillance) human clinical trials configured for international regulatory dossier submissions.
Commission individual laboratory assay phases or engage integrated ODM supply partnerships to advance your botanical drug or functional product lineup.
Whether you require targeted active ingredient screening, rigorous HPLC analytical method development, GLP toxicology documentation, or scalable CDMO commercial production, our scientists are ready to scope your project specifications.